neuropathic%20pain
NEUROPATHIC PAIN
Neuropathic pain is the sensation of pain due to abnormal discharges of impaired or injured neural structures in the peripheral &/or central nervous system.
It is characterized by hyperesthesia, hyperalgesia and allodynia.
Common neuropathic pain syndromes are central neuropathic pain, painful diabetic peripheral neuropathy, postherpetic neuralgia, trigeminal neuralgia, postsurgical neuropathic pain, HIV-related neuropathy, lumbosacral radiculopathy and complex regional pain syndrome.
  1. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010 Sep;17(9):1113-1123. doi: 10.1111/j.1468-1331.2010.02999.x. PMID: 20402746
  2. Chan A, Wong S, Chen PP, et al. Validation study of the Chinese Identification Pain Questionnaire for neuropathic pain. Hong Kong Med J. 2011 Aug;17(4):297-300. PMID: 21813898
  3. Chong MS, Bajwa ZH. Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage. 2003 May;25(Suppl 5):S4-S11. PMID: 12694987
  4. Beydoun A, Backonjia MM. Mechanistic stratification of antineuralgic agents. J Pain Symptom Manage. 2003 May;25(Suppl 5):S18-S30. PMID: 12694989
  5. Azhary H, Farooq MU, Bhanushali M, et al. Peripheral neuropathy: differential diagnosis and management. Am Fam Physician. 2010 Apr;81(7):887-892. PMID: 20353146
  6. Dubinsky RM, Kabbani H, El-Chami Z, et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004 Sep;63(6):959-965. PMID: 15452284
  7. Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010 Aug;17(8):1010-1018. PMID: 20298428
  8. Gilron I, Watson CP, Cahill CM, et al. Neuropathic pain: a practical guide for the clinician. CMAJ. 2006 Aug;175(3):265-275. PMID: 16880448
  9. Galluzzi KE. Management of neuropathic pain. J Am Osteopath Assoc. 2006 Sep(Suppl 4):S12-S18. PMID: 16273720
  10. Galluzzi K. Managing herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc. 2009 Jun;109(6)(Suppl 2):S7-S12. PMID: 19553635
  11. Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg. 2000;39(Suppl 5):S1-S60. PMID: 11280471
  12. Gronseth G, Alksne J, Argoff C, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008 Oct;71(15):1183-1190. PMID: 18716236
  13. Irving GA. Contemporary assessment and management of neuropathic pain. Neurology. 2005 Jun;64(12)(Suppl 3):S21-S27. PMID: 15999405
  14. Jefferies K. Treatment of neuropathic pain. Semin Neurol. 2010 Sep;30(4):425-432. PMID: 20941675
  15. Lunsford L, Niranjan A, Young R, et al. International Radiosurgery Association: stereotactic radiosurgery for patients with intractable typical trigeminal neuralgia who have failed medical management. Radiosurgery Practice Guideline Report. 2009 Jan:001-03. http://www.irsa.org/tn%20guideline-updatedjan2009.pdf.
  16. Jovin Z, Cvijanovic M, Ilin M, et al. Assessment of neuropathic pain and clinical evaluation of patients with suspected neuropathic pain. Curr Top Neurol Psychiatr Relat Discip. 2010 Jun;18(2):30-37
  17. Johnson RW, McElhaney J. Postherpetic neuralgia in the elderly. Int J Clin Pract. 2009 Sep;63(9):1386-1391. PMID: 19691624
  18. Ping CP, Ip JW, Lam J, et al. Multidisciplinary Panel on Neuropathic Pain: recommendations for the management of postherpetic neuralgia. Medical Progress. 2006;33(10):475-482. http://www.neuropainhk.org/Portals/0/mpnp-recommendations-postherpetic-neuralgia-update-oct-2006.pdf.
  19. Taliyan R, Sharma PL. Diabetic neuropathic pain: an update and novel pharmacological strategies for relief of pain. J Med Sci. 2010;10(4):93-109
  20. Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12(1):13-21. PMID: 17372630
  21. Várkonyi T, Putz Z, Keresztes K, et al. Current options and perspectives in the treatment of diabetic neuropathy. Curr Pharm Des. 2013;19(27):4981-5007. PMID: 23278494
  22. Ziegler D. Current Concepts in the management of diabetic polyneuropathy. Curr Diabetes Rev. 2011 May;7(3):208-220. PMID: 21534920
  23. Unger J. Pathogenesis, diagnosis and treatment of painful diabetic peripheral neuropathy. Applied Neurology. 2007 Feb(Suppl 1):006-15
  24. MedWormhttp://www.medworm.com/rss/index.php/Neurology/25/http://www.medworm.com/rss/medicalfeeds/specialities/Neurology.xml
  25. May S, Serpell M. Diagnosis and assessment of neuropathic pain. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948337/. Oct 2009. Accessed 21 Mar 2011
  26. American Society of Pain Educators. Diabetic peripheral neuropathic pain consensus guidelines for treatment. Supplement to The Journal of Family Practice. The Journal of Family Practice. http://www.jfponline.com/home/article/diabetic-peripheral-neuropathic-pain/142bfa8d9c5e06565462f6647bfe6418.html. Jun 2006. Accessed 21 Mar 2011
  27. U.S. Food and Drug Administration. Information for healthcare professionals: dangerous or even fatal skin reactions - carbamazapine. http://www.fda.gov/Drugs/DrugSafety/PostmarketdrugsafetyinformationforPatientsandProviders/ucm124718.htm. Accessed 07 Jun 2013
  28. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms and treatment. Lancet Neurol. 2010 Aug;9(8):807-819. doi: 10.1016/S1474-4422(10)70143-5. Accessed 3 Mar 2014. PMID: 20650402
  29. Bennett MI, Attal N, Backonjan MM, et al. Using screening tools to identify neuropathic pain. Pain. 2007;127(3):199-203. PMID: 17182186
  30. Vijayan R, Jin GK, Cardosa MS, et al. Malaysian guidelines on management of neuropathic pain. 2nd edition. Malaysian Association for the Study of Pain. www.masp.org.my. 2012.
  31. Great Manchester Medicines Management Group. Neuropathic pain guideline. GMMMG website. http://gmmmg.nhs.uk/docs/guidance/GMMMG%20Neuropathic%20Pain%20Guidance%20March%202014.pdf. Mar 2014.
  32. Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging. 1995 Oct;7(4):317-328. http://www.ncbi.nlm.nih.gov/pubmed/8535059. PMID: 8535059
  33. Attal N, Bouhassira D. Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? IASP. Pain. 2015 Apr;156(Suppl 1):S104-S114. doi: 10.1097/01.j.pain.0000460358.01998.15. PMID: 25789426
  34. Finnerup N, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: systematic review, meta-analysis and updated NeuPSIG recommendations. Lancet Neurol. 2015 Feb;14(2):162–173. doi: 10.1016/S1474-4422(14)70251-0. PMID: 25575710
  35. Haanpaa M, Hietaharju A. Halting the march of painful diabetic neuropathy. Pain. 2015 Apr;23(2):1-8. http://www.iasp-pain.org.
  36. Haanpaa M, Rice ASC, Rowbotham MC. Treating herpes zoster and postherpetic neuralgia. Pain: Clinical Updates. 2015 May;23(4):1-8. http://www.iasp-pain.org. .
  37. Klit H, Finnerup NB, Jensen TS. Diagnosis, prevalence, characteristics, and treatment of central poststroke pain. Pain: Clinical Updates. 2015 Apr;23(3):1-7. http://www.iasp-pain.org.
  38. Waldfogel JM, Nesbit SA, Dy SM, et al. Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: a systematic review. Neurology. 2017 Mar;88:1-10. doi: 10.1212/WNL.0000000000003882. PMID: 28341643
  39. Bajwa ZH, Ho CC, Khan SA. Trigeminal neuralgia. UpToDate. www.uptodate.com. Jan 2017. Accessed 13 Jul 2017.
  40. Emril DR, Ho KY. Treatment of trigeminal neuralgia: role of radiofrequency ablation. J Pain Res. 2010 Dec;3:249–254. doi: 10.2147/FJPR.S14455. PMID: 21311718
  41. Verheul JB, Hanssens PE, Lie ST, et al. Gamma knife surgery for trigeminal neuralgia: a review of 450 consecutive cases. J Neurosurg. 2010 Dec;113:160-167. doi: 10.3171/2010.7.GKS10978. PMID: 21121797
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 05 Oct 2017

Olfactory impairment in older adults may point to an elevated risk of developing Parkinson’s disease (PD), particularly in Caucasian men, a small US study found.

Radha Chitale, 01 Aug 2013

Facial paralysis can strike anyone at any time, but advances in understanding when to take surgical action can help improve patient outcomes more quickly, experts say.

01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
10 Nov 2017
Inhibition of hippocampal retrieval processes through gamma-aminobutyric acid (GABA) enables the suppression of intrusive thoughts, a recent study shows.